Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05602285 · ClinicalTrials.gov registry record
IV Dislodgement Comparative Effectiveness Study
A clinical trial, sponsored by The Cleveland Clinic.
- Terminated
- Registry status
- 2
- Enrollment target
NCT05602285: Clinical Trial study, sponsored by The Cleveland Clinic.
NCT05602285 is a clinical trial that was terminated before completion, run by The Cleveland Clinic. The registered enrollment target is 2 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05602285 was terminated before completion, sponsored by The Cleveland Clinic.
- TERMINATED
- Registry status
- 2 participants
- Enrollment target
Study Summary
The goal of this comparative effectiveness study is to compare IV dislodgement frequency in medical-surgical patients with continuous IV fluids infusing. The main question it aims to answer are: 1\. To determine if the addition of the break-away IV device within IV tubing and customary IV dressing reduces dislodgment when compared to customary IV dressing alone.
Primary Outcome
Frequency of IV dislodgements
Interventions
- DEVICE Dislodgement device
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2023-01-04 |
| Est. Completion | 2024-12-31 |
Why NCT05602285 stopped before completion
NCT05602285 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 2 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Dislodgement device is the first listed.
NCT05602285 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05602285 about?
NCT05602285 is a clinical study titled "IV Dislodgement Comparative Effectiveness Study". The goal of this comparative effectiveness study is to compare IV dislodgement frequency in medical-surgical patients with continuous IV fluids infusing. The main question it aims to answer are: 1\. To determine if the addition of the break-away IV device within IV tubing and customary IV dressing...
What is the current status of trial NCT05602285?
This trial is currently terminated. The enrollment target is 2 participants. The study started on 2023-01-04. Estimated completion is 2024-12-31.
What interventions are being tested in trial NCT05602285?
The interventions under investigation include: Dislodgement device (DEVICE).
Who is sponsoring clinical trial NCT05602285?
This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI